Table of Content

1 IDH1 Antibody Market Overview
1.1 Product Overview and Scope of IDH1 Antibody
1.2 IDH1 Antibody Segment by Type
1.2.1 Global IDH1 Antibody Market Value Comparison by Type (2023-2033)
1.2.2 Monoclonal
1.2.3 Polyclonal
1.3 IDH1 Antibody Segment by Application
1.3.1 Global IDH1 Antibody Market Value by Application: (2023-2033)
1.3.2 Immunochemistry (IHC)
1.3.3 Immunofluorescence (IF)
1.3.4 Immunoprecipitation (IP)
1.3.5 Western Blot (WB)
1.3.6 ELISA
1.3.7 Others
1.4 Global IDH1 Antibody Market Size Estimates and Forecasts
1.4.1 Global IDH1 Antibody Revenue 2018-2033
1.4.2 Global IDH1 Antibody Sales 2018-2033
1.4.3 Global IDH1 Antibody Market Average Price (2018-2033)
1.5 Assumptions and Limitations
2 IDH1 Antibody Market Competition by Manufacturers
2.1 Global IDH1 Antibody Sales Market Share by Manufacturers (2018-2023)
2.2 Global IDH1 Antibody Revenue Market Share by Manufacturers (2018-2023)
2.3 Global IDH1 Antibody Average Price by Manufacturers (2018-2023)
2.4 Global IDH1 Antibody Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of IDH1 Antibody, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of IDH1 Antibody, Product Type & Application
2.7 IDH1 Antibody Market Competitive Situation and Trends
2.7.1 IDH1 Antibody Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest IDH1 Antibody Players Market Share by Revenue
2.7.3 Global IDH1 Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 IDH1 Antibody Retrospective Market Scenario by Region
3.1 Global IDH1 Antibody Market Size by Region: 2018 Versus 2022 Versus 2033
3.2 Global IDH1 Antibody Global IDH1 Antibody Sales by Region: 2018-2033
3.2.1 Global IDH1 Antibody Sales by Region: 2018-2023
3.2.2 Global IDH1 Antibody Sales by Region: 2024-2033
3.3 Global IDH1 Antibody Global IDH1 Antibody Revenue by Region: 2018-2033
3.3.1 Global IDH1 Antibody Revenue by Region: 2018-2023
3.3.2 Global IDH1 Antibody Revenue by Region: 2024-2033
3.4 North America IDH1 Antibody Market Facts & Figures by Country
3.4.1 North America IDH1 Antibody Market Size by Country: 2018 VS 2022 VS 2033
3.4.2 North America IDH1 Antibody Sales by Country (2018-2033)
3.4.3 North America IDH1 Antibody Revenue by Country (2018-2033)
3.4.4 United States
3.4.5 Canada
3.5 Europe IDH1 Antibody Market Facts & Figures by Country
3.5.1 Europe IDH1 Antibody Market Size by Country: 2018 VS 2022 VS 2033
3.5.2 Europe IDH1 Antibody Sales by Country (2018-2033)
3.5.3 Europe IDH1 Antibody Revenue by Country (2018-2033)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific IDH1 Antibody Market Facts & Figures by Country
3.6.1 Asia Pacific IDH1 Antibody Market Size by Country: 2018 VS 2022 VS 2033
3.6.2 Asia Pacific IDH1 Antibody Sales by Country (2018-2033)
3.6.3 Asia Pacific IDH1 Antibody Revenue by Country (2018-2033)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America IDH1 Antibody Market Facts & Figures by Country
3.7.1 Latin America IDH1 Antibody Market Size by Country: 2018 VS 2022 VS 2033
3.7.2 Latin America IDH1 Antibody Sales by Country (2018-2033)
3.7.3 Latin America IDH1 Antibody Revenue by Country (2018-2033)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa IDH1 Antibody Market Facts & Figures by Country
3.8.1 Middle East and Africa IDH1 Antibody Market Size by Country: 2018 VS 2022 VS 2033
3.8.2 Middle East and Africa IDH1 Antibody Sales by Country (2018-2033)
3.8.3 Middle East and Africa IDH1 Antibody Revenue by Country (2018-2033)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global IDH1 Antibody Sales by Type (2018-2033)
4.1.1 Global IDH1 Antibody Sales by Type (2018-2023)
4.1.2 Global IDH1 Antibody Sales by Type (2024-2033)
4.1.3 Global IDH1 Antibody Sales Market Share by Type (2018-2033)
4.2 Global IDH1 Antibody Revenue by Type (2018-2033)
4.2.1 Global IDH1 Antibody Revenue by Type (2018-2023)
4.2.2 Global IDH1 Antibody Revenue by Type (2024-2033)
4.2.3 Global IDH1 Antibody Revenue Market Share by Type (2018-2033)
4.3 Global IDH1 Antibody Price by Type (2018-2033)
5 Segment by Application
5.1 Global IDH1 Antibody Sales by Application (2018-2033)
5.1.1 Global IDH1 Antibody Sales by Application (2018-2023)
5.1.2 Global IDH1 Antibody Sales by Application (2024-2033)
5.1.3 Global IDH1 Antibody Sales Market Share by Application (2018-2033)
5.2 Global IDH1 Antibody Revenue by Application (2018-2033)
5.2.1 Global IDH1 Antibody Revenue by Application (2018-2023)
5.2.2 Global IDH1 Antibody Revenue by Application (2024-2033)
5.2.3 Global IDH1 Antibody Revenue Market Share by Application (2018-2033)
5.3 Global IDH1 Antibody Price by Application (2018-2033)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck IDH1 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Merck IDH1 Antibody Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 GeneTex
6.2.1 GeneTex Corporation Information
6.2.2 GeneTex Description and Business Overview
6.2.3 GeneTex IDH1 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.2.4 GeneTex IDH1 Antibody Product Portfolio
6.2.5 GeneTex Recent Developments/Updates
6.3 Abcam
6.3.1 Abcam Corporation Information
6.3.2 Abcam Description and Business Overview
6.3.3 Abcam IDH1 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Abcam IDH1 Antibody Product Portfolio
6.3.5 Abcam Recent Developments/Updates
6.4 BosterBio
6.4.1 BosterBio Corporation Information
6.4.2 BosterBio Description and Business Overview
6.4.3 BosterBio IDH1 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.4.4 BosterBio IDH1 Antibody Product Portfolio
6.4.5 BosterBio Recent Developments/Updates
6.5 Proteintech Group
6.5.1 Proteintech Group Corporation Information
6.5.2 Proteintech Group Description and Business Overview
6.5.3 Proteintech Group IDH1 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Proteintech Group IDH1 Antibody Product Portfolio
6.5.5 Proteintech Group Recent Developments/Updates
6.6 Abnova Corporation
6.6.1 Abnova Corporation Corporation Information
6.6.2 Abnova Corporation Description and Business Overview
6.6.3 Abnova Corporation IDH1 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Abnova Corporation IDH1 Antibody Product Portfolio
6.6.5 Abnova Corporation Recent Developments/Updates
6.7 Novus Biologicals
6.6.1 Novus Biologicals Corporation Information
6.6.2 Novus Biologicals Description and Business Overview
6.6.3 Novus Biologicals IDH1 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Novus Biologicals IDH1 Antibody Product Portfolio
6.7.5 Novus Biologicals Recent Developments/Updates
6.8 NSJ Bioreagents
6.8.1 NSJ Bioreagents Corporation Information
6.8.2 NSJ Bioreagents Description and Business Overview
6.8.3 NSJ Bioreagents IDH1 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.8.4 NSJ Bioreagents IDH1 Antibody Product Portfolio
6.8.5 NSJ Bioreagents Recent Developments/Updates
6.9 LifeSpan BioSciences
6.9.1 LifeSpan BioSciences Corporation Information
6.9.2 LifeSpan BioSciences Description and Business Overview
6.9.3 LifeSpan BioSciences IDH1 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.9.4 LifeSpan BioSciences IDH1 Antibody Product Portfolio
6.9.5 LifeSpan BioSciences Recent Developments/Updates
6.10 Abeomics
6.10.1 Abeomics Corporation Information
6.10.2 Abeomics Description and Business Overview
6.10.3 Abeomics IDH1 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Abeomics IDH1 Antibody Product Portfolio
6.10.5 Abeomics Recent Developments/Updates
6.11 ProSci
6.11.1 ProSci Corporation Information
6.11.2 ProSci IDH1 Antibody Description and Business Overview
6.11.3 ProSci IDH1 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.11.4 ProSci IDH1 Antibody Product Portfolio
6.11.5 ProSci Recent Developments/Updates
6.12 QED Bioscience
6.12.1 QED Bioscience Corporation Information
6.12.2 QED Bioscience IDH1 Antibody Description and Business Overview
6.12.3 QED Bioscience IDH1 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.12.4 QED Bioscience IDH1 Antibody Product Portfolio
6.12.5 QED Bioscience Recent Developments/Updates
6.13 Cell Signaling Technology
6.13.1 Cell Signaling Technology Corporation Information
6.13.2 Cell Signaling Technology IDH1 Antibody Description and Business Overview
6.13.3 Cell Signaling Technology IDH1 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Cell Signaling Technology IDH1 Antibody Product Portfolio
6.13.5 Cell Signaling Technology Recent Developments/Updates
6.14 RayBiotech
6.14.1 RayBiotech Corporation Information
6.14.2 RayBiotech IDH1 Antibody Description and Business Overview
6.14.3 RayBiotech IDH1 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.14.4 RayBiotech IDH1 Antibody Product Portfolio
6.14.5 RayBiotech Recent Developments/Updates
6.15 EpiGentek
6.15.1 EpiGentek Corporation Information
6.15.2 EpiGentek IDH1 Antibody Description and Business Overview
6.15.3 EpiGentek IDH1 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.15.4 EpiGentek IDH1 Antibody Product Portfolio
6.15.5 EpiGentek Recent Developments/Updates
6.16 Enzo Life Sciences
6.16.1 Enzo Life Sciences Corporation Information
6.16.2 Enzo Life Sciences IDH1 Antibody Description and Business Overview
6.16.3 Enzo Life Sciences IDH1 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Enzo Life Sciences IDH1 Antibody Product Portfolio
6.16.5 Enzo Life Sciences Recent Developments/Updates
6.17 OriGene Technologies
6.17.1 OriGene Technologies Corporation Information
6.17.2 OriGene Technologies IDH1 Antibody Description and Business Overview
6.17.3 OriGene Technologies IDH1 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.17.4 OriGene Technologies IDH1 Antibody Product Portfolio
6.17.5 OriGene Technologies Recent Developments/Updates
6.18 Jingjie PTM BioLab
6.18.1 Jingjie PTM BioLab Corporation Information
6.18.2 Jingjie PTM BioLab IDH1 Antibody Description and Business Overview
6.18.3 Jingjie PTM BioLab IDH1 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.18.4 Jingjie PTM BioLab IDH1 Antibody Product Portfolio
6.18.5 Jingjie PTM BioLab Recent Developments/Updates
6.19 Beijing Solarbio
6.19.1 Beijing Solarbio Corporation Information
6.19.2 Beijing Solarbio IDH1 Antibody Description and Business Overview
6.19.3 Beijing Solarbio IDH1 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.19.4 Beijing Solarbio IDH1 Antibody Product Portfolio
6.19.5 Beijing Solarbio Recent Developments/Updates
6.20 Biobyt
6.20.1 Biobyt Corporation Information
6.20.2 Biobyt IDH1 Antibody Description and Business Overview
6.20.3 Biobyt IDH1 Antibody Sales, Revenue and Gross Margin (2018-2023)
6.20.4 Biobyt IDH1 Antibody Product Portfolio
6.20.5 Biobyt Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 IDH1 Antibody Industry Chain Analysis
7.2 IDH1 Antibody Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 IDH1 Antibody Production Mode & Process
7.4 IDH1 Antibody Sales and Marketing
7.4.1 IDH1 Antibody Sales Channels
7.4.2 IDH1 Antibody Distributors
7.5 IDH1 Antibody Customers
8 IDH1 Antibody Market Dynamics
8.1 IDH1 Antibody Industry Trends
8.2 IDH1 Antibody Market Drivers
8.3 IDH1 Antibody Market Challenges
8.4 IDH1 Antibody Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global IDH1 Antibody Market Value Comparison by Type (2023-2033) & (US$ Million)
Table 2. Global IDH1 Antibody Market Value Comparison by Application (2023-2033) & (US$ Million)
Table 3. Global IDH1 Antibody Market Competitive Situation by Manufacturers in 2022
Table 4. Global IDH1 Antibody Sales (ml) of Key Manufacturers (2018-2023)
Table 5. Global IDH1 Antibody Sales Market Share by Manufacturers (2018-2023)
Table 6. Global IDH1 Antibody Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global IDH1 Antibody Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market IDH1 Antibody Average Price (US$/ml) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of IDH1 Antibody, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of IDH1 Antibody, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of IDH1 Antibody, Product Type & Application
Table 12. Global Key Manufacturers of IDH1 Antibody, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global IDH1 Antibody by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in IDH1 Antibody as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global IDH1 Antibody Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 17. Global IDH1 Antibody Sales by Region (2018-2023) & (ml)
Table 18. Global IDH1 Antibody Sales Market Share by Region (2018-2023)
Table 19. Global IDH1 Antibody Sales by Region (2024-2033) & (ml)
Table 20. Global IDH1 Antibody Sales Market Share by Region (2024-2033)
Table 21. Global IDH1 Antibody Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global IDH1 Antibody Revenue Market Share by Region (2018-2023)
Table 23. Global IDH1 Antibody Revenue by Region (2024-2033) & (US$ Million)
Table 24. Global IDH1 Antibody Revenue Market Share by Region (2024-2033)
Table 25. North America IDH1 Antibody Revenue by Country: 2018 VS 2022 VS 2033 (US$ Million)
Table 26. North America IDH1 Antibody Sales by Country (2018-2023) & (ml)
Table 27. North America IDH1 Antibody Sales by Country (2024-2033) & (ml)
Table 28. North America IDH1 Antibody Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America IDH1 Antibody Revenue by Country (2024-2033) & (US$ Million)
Table 30. Europe IDH1 Antibody Revenue by Country: 2018 VS 2022 VS 2033 (US$ Million)
Table 31. Europe IDH1 Antibody Sales by Country (2018-2023) & (ml)
Table 32. Europe IDH1 Antibody Sales by Country (2024-2033) & (ml)
Table 33. Europe IDH1 Antibody Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe IDH1 Antibody Revenue by Country (2024-2033) & (US$ Million)
Table 35. Asia Pacific IDH1 Antibody Revenue by Region: 2018 VS 2022 VS 2033 (US$ Million)
Table 36. Asia Pacific IDH1 Antibody Sales by Region (2018-2023) & (ml)
Table 37. Asia Pacific IDH1 Antibody Sales by Region (2024-2033) & (ml)
Table 38. Asia Pacific IDH1 Antibody Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific IDH1 Antibody Revenue by Region (2024-2033) & (US$ Million)
Table 40. Latin America IDH1 Antibody Revenue by Country: 2018 VS 2022 VS 2033 (US$ Million)
Table 41. Latin America IDH1 Antibody Sales by Country (2018-2023) & (ml)
Table 42. Latin America IDH1 Antibody Sales by Country (2024-2033) & (ml)
Table 43. Latin America IDH1 Antibody Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America IDH1 Antibody Revenue by Country (2024-2033) & (US$ Million)
Table 45. Middle East & Africa IDH1 Antibody Revenue by Country: 2018 VS 2022 VS 2033 (US$ Million)
Table 46. Middle East & Africa IDH1 Antibody Sales by Country (2018-2023) & (ml)
Table 47. Middle East & Africa IDH1 Antibody Sales by Country (2024-2033) & (ml)
Table 48. Middle East & Africa IDH1 Antibody Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa IDH1 Antibody Revenue by Country (2024-2033) & (US$ Million)
Table 50. Global IDH1 Antibody Sales (ml) by Type (2018-2023)
Table 51. Global IDH1 Antibody Sales (ml) by Type (2024-2033)
Table 52. Global IDH1 Antibody Sales Market Share by Type (2018-2023)
Table 53. Global IDH1 Antibody Sales Market Share by Type (2024-2033)
Table 54. Global IDH1 Antibody Revenue (US$ Million) by Type (2018-2023)
Table 55. Global IDH1 Antibody Revenue (US$ Million) by Type (2024-2033)
Table 56. Global IDH1 Antibody Revenue Market Share by Type (2018-2023)
Table 57. Global IDH1 Antibody Revenue Market Share by Type (2024-2033)
Table 58. Global IDH1 Antibody Price (US$/ml) by Type (2018-2023)
Table 59. Global IDH1 Antibody Price (US$/ml) by Type (2024-2033)
Table 60. Global IDH1 Antibody Sales (ml) by Application (2018-2023)
Table 61. Global IDH1 Antibody Sales (ml) by Application (2024-2033)
Table 62. Global IDH1 Antibody Sales Market Share by Application (2018-2023)
Table 63. Global IDH1 Antibody Sales Market Share by Application (2024-2033)
Table 64. Global IDH1 Antibody Revenue (US$ Million) by Application (2018-2023)
Table 65. Global IDH1 Antibody Revenue (US$ Million) by Application (2024-2033)
Table 66. Global IDH1 Antibody Revenue Market Share by Application (2018-2023)
Table 67. Global IDH1 Antibody Revenue Market Share by Application (2024-2033)
Table 68. Global IDH1 Antibody Price (US$/ml) by Application (2018-2023)
Table 69. Global IDH1 Antibody Price (US$/ml) by Application (2024-2033)
Table 70. Merck Corporation Information
Table 71. Merck Description and Business Overview
Table 72. Merck IDH1 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2018-2023)
Table 73. Merck IDH1 Antibody Product
Table 74. Merck Recent Developments/Updates
Table 75. GeneTex Corporation Information
Table 76. GeneTex Description and Business Overview
Table 77. GeneTex IDH1 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2018-2023)
Table 78. GeneTex IDH1 Antibody Product
Table 79. GeneTex Recent Developments/Updates
Table 80. Abcam Corporation Information
Table 81. Abcam Description and Business Overview
Table 82. Abcam IDH1 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2018-2023)
Table 83. Abcam IDH1 Antibody Product
Table 84. Abcam Recent Developments/Updates
Table 85. BosterBio Corporation Information
Table 86. BosterBio Description and Business Overview
Table 87. BosterBio IDH1 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2018-2023)
Table 88. BosterBio IDH1 Antibody Product
Table 89. BosterBio Recent Developments/Updates
Table 90. Proteintech Group Corporation Information
Table 91. Proteintech Group Description and Business Overview
Table 92. Proteintech Group IDH1 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2018-2023)
Table 93. Proteintech Group IDH1 Antibody Product
Table 94. Proteintech Group Recent Developments/Updates
Table 95. Abnova Corporation Corporation Information
Table 96. Abnova Corporation Description and Business Overview
Table 97. Abnova Corporation IDH1 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2018-2023)
Table 98. Abnova Corporation IDH1 Antibody Product
Table 99. Abnova Corporation Recent Developments/Updates
Table 100. Novus Biologicals Corporation Information
Table 101. Novus Biologicals Description and Business Overview
Table 102. Novus Biologicals IDH1 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2018-2023)
Table 103. Novus Biologicals IDH1 Antibody Product
Table 104. Novus Biologicals Recent Developments/Updates
Table 105. NSJ Bioreagents Corporation Information
Table 106. NSJ Bioreagents Description and Business Overview
Table 107. NSJ Bioreagents IDH1 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2018-2023)
Table 108. NSJ Bioreagents IDH1 Antibody Product
Table 109. NSJ Bioreagents Recent Developments/Updates
Table 110. LifeSpan BioSciences Corporation Information
Table 111. LifeSpan BioSciences Description and Business Overview
Table 112. LifeSpan BioSciences IDH1 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2018-2023)
Table 113. LifeSpan BioSciences IDH1 Antibody Product
Table 114. LifeSpan BioSciences Recent Developments/Updates
Table 115. Abeomics Corporation Information
Table 116. Abeomics Description and Business Overview
Table 117. Abeomics IDH1 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2018-2023)
Table 118. Abeomics IDH1 Antibody Product
Table 119. Abeomics Recent Developments/Updates
Table 120. ProSci Corporation Information
Table 121. ProSci Description and Business Overview
Table 122. ProSci IDH1 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2018-2023)
Table 123. ProSci IDH1 Antibody Product
Table 124. ProSci Recent Developments/Updates
Table 125. QED Bioscience Corporation Information
Table 126. QED Bioscience Description and Business Overview
Table 127. QED Bioscience IDH1 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2018-2023)
Table 128. QED Bioscience IDH1 Antibody Product
Table 129. QED Bioscience Recent Developments/Updates
Table 130. Cell Signaling Technology Corporation Information
Table 131. Cell Signaling Technology Description and Business Overview
Table 132. Cell Signaling Technology IDH1 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2018-2023)
Table 133. Cell Signaling Technology IDH1 Antibody Product
Table 134. Cell Signaling Technology Recent Developments/Updates
Table 135. RayBiotech Corporation Information
Table 136. RayBiotech Description and Business Overview
Table 137. RayBiotech IDH1 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2018-2023)
Table 138. RayBiotech IDH1 Antibody Product
Table 139. RayBiotech Recent Developments/Updates
Table 140. EpiGentek Corporation Information
Table 141. EpiGentek Description and Business Overview
Table 142. EpiGentek IDH1 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2018-2023)
Table 143. EpiGentek IDH1 Antibody Product
Table 144. EpiGentek Recent Developments/Updates
Table 145. Enzo Life Sciences Corporation Information
Table 146. Enzo Life Sciences Description and Business Overview
Table 147. Enzo Life Sciences IDH1 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2018-2023)
Table 148. Enzo Life Sciences IDH1 Antibody Product
Table 149. Enzo Life Sciences Recent Developments/Updates
Table 150. OriGene Technologies Corporation Information
Table 151. OriGene Technologies Description and Business Overview
Table 152. OriGene Technologies IDH1 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2018-2023)
Table 153. OriGene Technologies IDH1 Antibody Product
Table 154. OriGene Technologies Recent Developments/Updates
Table 155. Jingjie PTM BioLab Corporation Information
Table 156. Jingjie PTM BioLab Description and Business Overview
Table 157. Jingjie PTM BioLab IDH1 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2018-2023)
Table 158. Jingjie PTM BioLab IDH1 Antibody Product
Table 159. Jingjie PTM BioLab Recent Developments/Updates
Table 160. Beijing Solarbio Corporation Information
Table 161. Beijing Solarbio Description and Business Overview
Table 162. Beijing Solarbio IDH1 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2018-2023)
Table 163. Beijing Solarbio IDH1 Antibody Product
Table 164. Beijing Solarbio Recent Developments/Updates
Table 165. Biobyt Corporation Information
Table 166. Biobyt Description and Business Overview
Table 167. Biobyt IDH1 Antibody Sales (ml), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2018-2023)
Table 168. Biobyt IDH1 Antibody Product
Table 169. Biobyt Recent Developments/Updates
Table 170. Key Raw Materials Lists
Table 171. Raw Materials Key Suppliers Lists
Table 172. IDH1 Antibody Distributors List
Table 173. IDH1 Antibody Customers List
Table 174. IDH1 Antibody Market Trends
Table 175. IDH1 Antibody Market Drivers
Table 176. IDH1 Antibody Market Challenges
Table 177. IDH1 Antibody Market Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of IDH1 Antibody
Figure 2. Global IDH1 Antibody Market Value Comparison by Type (2023-2033) & (US$ Million)
Figure 3. Global IDH1 Antibody Market Share by Type in 2022 & 2033
Figure 4. Monoclonal Product Picture
Figure 5. Polyclonal Product Picture
Figure 6. Global IDH1 Antibody Market Value Comparison by Application (2023-2033) & (US$ Million)
Figure 7. Global IDH1 Antibody Market Share by Application in 2022 & 2033
Figure 8. Immunochemistry (IHC)
Figure 9. Immunofluorescence (IF)
Figure 10. Immunoprecipitation (IP)
Figure 11. Western Blot (WB)
Figure 12. ELISA
Figure 13. Others
Figure 14. Global IDH1 Antibody Revenue, (US$ Million), 2018 VS 2022 VS 2033
Figure 15. Global IDH1 Antibody Market Size (2018-2033) & (US$ Million)
Figure 16. Global IDH1 Antibody Sales (2018-2033) & (ml)
Figure 17. Global IDH1 Antibody Average Price (US$/ml) & (2018-2033)
Figure 18. IDH1 Antibody Report Years Considered
Figure 19. IDH1 Antibody Sales Share by Manufacturers in 2022
Figure 20. Global IDH1 Antibody Revenue Share by Manufacturers in 2022
Figure 21. The Global 5 and 10 Largest IDH1 Antibody Players: Market Share by Revenue in 2022
Figure 22. IDH1 Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 23. Global IDH1 Antibody Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Figure 24. North America IDH1 Antibody Sales Market Share by Country (2018-2033)
Figure 25. North America IDH1 Antibody Revenue Market Share by Country (2018-2033)
Figure 26. United States IDH1 Antibody Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 27. Canada IDH1 Antibody Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 28. Europe IDH1 Antibody Sales Market Share by Country (2018-2033)
Figure 29. Europe IDH1 Antibody Revenue Market Share by Country (2018-2033)
Figure 30. Germany IDH1 Antibody Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 31. France IDH1 Antibody Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 32. U.K. IDH1 Antibody Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 33. Italy IDH1 Antibody Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 34. Russia IDH1 Antibody Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 35. Asia Pacific IDH1 Antibody Sales Market Share by Region (2018-2033)
Figure 36. Asia Pacific IDH1 Antibody Revenue Market Share by Region (2018-2033)
Figure 37. China IDH1 Antibody Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 38. Japan IDH1 Antibody Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 39. South Korea IDH1 Antibody Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 40. India IDH1 Antibody Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 41. Australia IDH1 Antibody Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 42. China Taiwan IDH1 Antibody Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 43. Southeast Asia IDH1 Antibody Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 44. Latin America IDH1 Antibody Sales Market Share by Country (2018-2033)
Figure 45. Latin America IDH1 Antibody Revenue Market Share by Country (2018-2033)
Figure 46. Mexico IDH1 Antibody Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 47. Brazil IDH1 Antibody Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 48. Argentina IDH1 Antibody Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 49. Colombia IDH1 Antibody Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 50. Middle East & Africa IDH1 Antibody Sales Market Share by Country (2018-2033)
Figure 51. Middle East & Africa IDH1 Antibody Revenue Market Share by Country (2018-2033)
Figure 52. Turkey IDH1 Antibody Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 53. Saudi Arabia IDH1 Antibody Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 54. UAE IDH1 Antibody Revenue Growth Rate (2018-2033) & (US$ Million)
Figure 55. Global Sales Market Share of IDH1 Antibody by Type (2018-2033)
Figure 56. Global Revenue Market Share of IDH1 Antibody by Type (2018-2033)
Figure 57. Global IDH1 Antibody Price (US$/ml) by Type (2018-2033)
Figure 58. Global Sales Market Share of IDH1 Antibody by Application (2018-2033)
Figure 59. Global Revenue Market Share of IDH1 Antibody by Application (2018-2033)
Figure 60. Global IDH1 Antibody Price (US$/ml) by Application (2018-2033)
Figure 61. IDH1 Antibody Value Chain
Figure 62. IDH1 Antibody Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed